The Paediatric Rheumatology European Society (PReS) has over many years, developed a portfolio of educational activities to address increasing educational needs of workforce and support young clinicians to acquire skills to develop new knowledge and deliver clinical care in the future. These educational activities aim to facilitate growth of...
-
2018 (v1)PublicationUploaded on: April 14, 2023
-
2021 (v1)Publication
Objective: To develop and validate new Juvenile Arthritis Disease Activity Score 10 (JADAS10) and clinical JADAS10 (cJADAS10) cutoffs to separate the states of inactive disease (ID), minimal disease activity (MiDA), moderate disease activity (MoDA), and high disease activity (HDA) in children with oligoarthritis and with rheumatoid...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
In the first version of the paper, two of the three subheadings in Table 2 were spelt incorrectly. Takayasu Arthritis has vbeen changed to Takayasu arteritis. This error only appeared in two subheadings. The stated recommendations and main article text have not been affected or changed. The Publisher and authors apologise for this error.
Uploaded on: April 14, 2023 -
2016 (v1)Publication
Objective. The main objective was to determine the 2-year clinical benefit and safety of etanercept (ETN) in children with the juvenile idiopathic arthritis (JIA) categories of extended oligoarthritis (eoJIA), enthesitis-related arthritis (ERA), or psoriatic arthritis (PsA). Methods. CLIPPER was a 96-week, phase IIIb, open-label, multicenter...
Uploaded on: April 14, 2023 -
2014 (v1)Publication
Background: Rheumatic diseases in children are associated with significant morbidity and poor health-related quality of life (HRQOL). There is no health-related quality of life (HRQOL) scale available specifically for children with less common rheumatic diseases. These diseases share several features with systemic lupus erythematosus (SLE) such...
Uploaded on: April 14, 2023 -
2009 (v1)Publication
In recent years, antiphospholipid syndrome (APS) has been increasingly recognised in various paediatric autoimmune and nonautoimmune diseases, but the relatively low prevalence and heterogeneity of APS in childhood made it very difficult to study in a systematic way. The project of an international registry of paediatric patients with APS (the...
Uploaded on: April 14, 2023